Daratumumab for the treatment of relapsed/refractory AL amyloidosis: experience from the amyloidosis Program of Calgary (APC) Daniel Levin,Ellen Lewis,Sylvia McCulloch,Holly Lee,Jason Tay,Peter Duggan,Paola Neri,Nizar Bahlis,Victor H. Jimenez-ZepedaLeukemia & lymphoma(2024)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要